Prelude Therapeutics Cash from Financing (TTM) Trends

Prelude Therapeutics Inc (PRLD)

4.08 +0.49 (+13.65%) USD | NASDAQ | May 09, 16:00

4.07 -0.01 (-0.25%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	136.65M
December 31, 2023	136.40M
September 30, 2023	111.31M
June 30, 2023	111.37M
March 31, 2023	0.393M
December 31, 2022	0.815M
September 30, 2022	2.614M

Date	Value
June 30, 2022	3.177M
March 31, 2022	3.24M
December 31, 2021	164.90M
September 30, 2021	161.64M
June 30, 2021	378.68M
March 31, 2021	378.19M
December 31, 2020	246.23M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.393M

Minimum

Mar 2023

378.68M

Maximum

Jun 2021

131.11M

Average

123.88M

Median

Cash from Financing (TTM) Benchmarks